A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Article Published on 2023-01-312023-07-11 Journal: Cell Reports [Category] COVID19(2023년), [키워드] ACE2 receptor antigenic variation BA.2.75 COVID-19 CP: Immunology CP: Microbiology Immune escape RBD SARS-CoV-2 spike variant Variant of concern. [DOI] 10.1016/j.celrep.2022.111903 PMC 바로가기
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy새로운 SARS-CoV-2 변종인 Omicron: 중증도 및 백신 효능에 대한 영향 평가Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Comment COVID-19 COVID-19 vaccine distribution Efficacy India Mild new SARS-CoV-2 omicron rising RT-PCR testing SARS-CoV-2 severity Vaccine vaccine candidate vaccine efficacy vaccine efficacy. Vaccine hesitancy variant variant of SARS-CoV-2 [DOI] 10.1080/21645515.2022.2034458 PMC 바로가기 [Article Type] Article
Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan일본 의료 센터에서 BNT162b2 mRNA COVID-19 백신의 효과 및 돌파구에 대한 실제 증거Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Asia Asian BNT162b2 BNT162b2 vaccine breakthrough COVID-19 vaccine delta variant demonstrated Effectiveness Effectiveness. Evidence evidence of hospital hygiene Infection infection control Japan measure mRNA of BNT162b2 Population populations Public hygiene Regulation required retrospective cohort study SARS-CoV-2 Spread Tokyo vaccination Vaccine variant while [DOI] 10.1080/21645515.2021.1984124 PMC 바로가기 [Article Type] Article
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective글로벌 관점에서 COVID-19 백신 부스터의 물류 판단Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] booster booster vaccination booster vaccinations COVID-19 COVID-19 vaccination COVID-19 vaccine Effectiveness equity Immune escape Immune-mediated immunocompromised individuals implementation indicate Perspective Premature protective immunity protocol response SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Side effects vaccination Vaccine Vaccine hesitancy vaccine. variant viral evolution waning immunity weighed [DOI] 10.1080/21645515.2021.2020572 PMC 바로가기 [Article Type] Article
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & JohnsonSARS-CoV-2 백신에 대한 포괄적인 검토: Pfizer, Moderna & Johnson & JohnsonReview Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Adenovirus administration age approval clinical clinical trial clinical trials coronavirus coronavirus. COVID-19 COVID-19 vaccine COVID-19 vaccines effective Efficacy General population group Johnson Johnson & Johnson Johnson & large cohort mechanism moderate Moderna mRNA vaccines Novel coronavirus ongoing trial ongoing trials outbreak pandemic participant Pfizer Safety SARS-CoV-2 SARS-CoV-2 coronavirus SARS-COV-2 infection shown Side effects Spike protein symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 the spike protein the United State Trial United States Vaccinations Vaccine vaccine administration variant [DOI] 10.1080/21645515.2021.2002083 PMC 바로가기 [Article Type] Review
Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communitiesArticle Published on 2022-12-202022-11-16 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, [키워드] allelic Alpha variant anticipated Canada clinical clinical testing Community complement COVID-19 COVID-19 pandemic decrease Delta VOC diagnostic Effectiveness effort eligibility Endemic epidemiological Epidemiology greater identify Immunity in-depth analysis increases in infection control investigated Metrics occurred omicron Pandemics population immunity proportion public health Public-health reduction reduction in reported required resulting SARS-CoV-2 Seven significant decrease significant increases in significantly Surveillance the disease the SARS-CoV-2 variant variants of concern VoC wastewater wastewater surveillance Wastewater-based epidemiology. [DOI] 10.1016/j.scitotenv.2022.158547 PMC 바로가기
Impact of SARS-CoV-2 variants on mobility and air pollution in the United KingdomArticle Published on 2022-12-102022-11-16 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] activity affecting Algorithm Alpha baseline baseline level baseline levels contagiousness COVID-19 COVID-19 case death Delta event Government Immunity Impact Increases measure NO(2) normality Pollution prevalent Public public health reduced remained Result returned SARS-CoV-2 variant significant increase significantly social contact Spread Traffic Traffic. United Kingdom variant variants virus wildtype [DOI] 10.1016/j.scitotenv.2022.158279 PMC 바로가기
Sewage surveillance of SARS-CoV-2 at student campus residences in the Western Cape, South AfricaArticle Published on 2022-12-102022-11-15 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] activity acute respiratory syndrome Cape collected coronavirus coronavirus disease country COVID-19 defined Delta diagnostic Efficacy Epidemiology evaluated genotyping Infection infections institution management monitoring Near-source WBE omicron outbreak Passive Passive sampling reported RT-qPCR SARS-CoV-2 sewage South Africa Stellenbosch Stellenbosch University student Student campus residences Surveillance Thermo Fisher variant wastewater Wastewater-based epidemiology. [DOI] 10.1016/j.scitotenv.2022.158028 PMC 바로가기
Clinical course of patients with chronic limb-threatening ischemia developing COVID-19Article Published on 2022-12-012022-11-16 Journal: Journal of cardiology [Category] 변종, [키워드] 30-Day mortality 95 % CI acute respiratory syndrome added Analysis association calculated Cardiovascular events caused chronic Chronic limb-threatening ischemia claudication clinical Clinical course confidence interval control group coronavirus Course COVID-19 COVID-19 pandemic COVID-19 patient Cox regression analysis demonstrated diagnosis of COVID-19 disease evaluate the effect hazard ratio Healthcare systems high risk increased risk initial IPW Ischemia Japan Mortality mortality risk omicron omicron variant. pandemic Patient patients patients with COVID-19 primary outcome measure Probability proportion reached Regression model reported significantly higher treated Treatment variant was used Weighting [DOI] 10.1016/j.jjcc.2022.07.010 PMC 바로가기